Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial

Faster, Cleaner, Better.

Prevail Therapeutics Inc (PRVL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	06-2019	03-2019	12-2018	09-2018	06-2018
Cash Flows From Operating Activities
Net Income	-25,048	-9,945	-19,087	-12,339	-7,141
Depreciation Amortization	93	37	526	500	485
Accounts payable and accrued liabilities	762	712	N/A	1,867	1,334
Other Working Capital	780	-3,029	2,147	1,577	1,265
Other Operating Activity	959	-100	2,403	15	70
Operating Cash Flow	$-22,454	$-12,325	$-14,011	$-8,380	$-3,987

Cash Flows From Investing Activities
PPE Investments	-1,538	-256	-627	-304	-167
Investing Cash Flow	$-1,538	$-256	$-627	$-304	$-167

Cash Flows From Financing Activities
Common Stock Issued	116,255	N/A	N/A	N/A	N/A
Other Financing Activity	46,818	49,834	64,907	64,907	64,907
Financing Cash Flow	$163,073	$49,834	$64,907	$64,907	$64,907

Beginning Cash Position	63,105	63,106	12,836	12,836	12,836
End Cash Position	202,186	100,359	63,105	69,059	73,589
Net Cash Flow	$139,081	$37,253	$50,269	$56,223	$60,753

Free Cash Flow
Operating Cash Flow	-22,454	-12,325	-14,011	-8,380	-3,987
Capital Expenditure	-1,538	-256	N/A	-304	-167
Free Cash Flow	-23,992	-12,581	-14,011	-8,684	-4,154